Matinas BioPharma
MTNB
NZ$1.47
Share price
-5.85%
Change (1 day)
-89.55%
Change (1 year)
Categories
Revenue for Matinas BioPharma (MTNB)
Revenue in 2025 (TTM): N/A
In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of NZ$1.73 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Matinas BioPharma from 2013 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
2025 (TTM)  | N/A | |
| 2024 | N/A | -100% |
| 2023 | NZ$1.73 M | -65.5% |
| 2022 | NZ$5.02 M | 10192.53% |
| 2021 | NZ$0.04 M | -77.76% |
| 2020 | NZ$0.21 M | 64.55% |
| 2019 | NZ$0.13 M | -25.3% |
| 2018 | NZ$0.17 M | -15.3% |
| 2017 | NZ$0.21 M | |
| 2016 | N/A | -100% |
| 2015 | NZ$0.28 M | |
| 2014 | N/A | |
| 2013 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |